20-49372990-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_004975.4(KCNB1):​c.2570G>A​(p.Ser857Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,608,510 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 10 hom., cov: 32)
Exomes 𝑓: 0.011 ( 132 hom. )

Consequence

KCNB1
NM_004975.4 missense

Scores

8
10

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.92

Publications

12 publications found
Variant links:
Genes affected
KCNB1 (HGNC:6231): (potassium voltage-gated channel subfamily B member 1) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shab-related subfamily. This member is a delayed rectifier potassium channel and its activity is modulated by some other family members. [provided by RefSeq, Jul 2008]
KCNB1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 26
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059853196).
BP6
Variant 20-49372990-C-T is Benign according to our data. Variant chr20-49372990-C-T is described in ClinVar as [Benign]. Clinvar id is 380824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1402 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNB1NM_004975.4 linkc.2570G>A p.Ser857Asn missense_variant Exon 2 of 2 ENST00000371741.6 NP_004966.1 Q14721
KCNB1XM_011528799.3 linkc.2570G>A p.Ser857Asn missense_variant Exon 3 of 3 XP_011527101.1 Q14721
LOC105372649XR_001754659.2 linkn.1201+40966C>T intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNB1ENST00000371741.6 linkc.2570G>A p.Ser857Asn missense_variant Exon 2 of 2 1 NM_004975.4 ENSP00000360806.3 Q14721

Frequencies

GnomAD3 genomes
AF:
0.00922
AC:
1402
AN:
152074
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00169
Gnomad AMI
AF:
0.00440
Gnomad AMR
AF:
0.00643
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0106
Gnomad FIN
AF:
0.0288
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0122
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.0102
AC:
2519
AN:
245830
AF XY:
0.0110
show subpopulations
Gnomad AFR exome
AF:
0.00112
Gnomad AMR exome
AF:
0.00391
Gnomad ASJ exome
AF:
0.00852
Gnomad EAS exome
AF:
0.000166
Gnomad FIN exome
AF:
0.0313
Gnomad NFE exome
AF:
0.0110
Gnomad OTH exome
AF:
0.00886
GnomAD4 exome
AF:
0.0108
AC:
15744
AN:
1456318
Hom.:
132
Cov.:
32
AF XY:
0.0110
AC XY:
8004
AN XY:
724384
show subpopulations
African (AFR)
AF:
0.00150
AC:
50
AN:
33260
American (AMR)
AF:
0.00392
AC:
173
AN:
44096
Ashkenazi Jewish (ASJ)
AF:
0.00915
AC:
235
AN:
25688
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39670
South Asian (SAS)
AF:
0.0121
AC:
1030
AN:
85376
European-Finnish (FIN)
AF:
0.0261
AC:
1391
AN:
53236
Middle Eastern (MID)
AF:
0.00552
AC:
29
AN:
5256
European-Non Finnish (NFE)
AF:
0.0110
AC:
12251
AN:
1109644
Other (OTH)
AF:
0.00970
AC:
583
AN:
60092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
775
1550
2326
3101
3876
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00921
AC:
1402
AN:
152192
Hom.:
10
Cov.:
32
AF XY:
0.0102
AC XY:
762
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.00169
AC:
70
AN:
41530
American (AMR)
AF:
0.00642
AC:
98
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0106
AC:
51
AN:
4826
European-Finnish (FIN)
AF:
0.0288
AC:
305
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0122
AC:
829
AN:
67998
Other (OTH)
AF:
0.00664
AC:
14
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
69
139
208
278
347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00989
Hom.:
29
Bravo
AF:
0.00677
TwinsUK
AF:
0.0116
AC:
43
ALSPAC
AF:
0.0127
AC:
49
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.0105
AC:
90
ExAC
AF:
0.00968
AC:
1175
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 15, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KCNB1: BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Feb 10, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Developmental and epileptic encephalopathy, 26 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
T;T
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.43
.;T
MetaRNN
Benign
0.0060
T;T
MetaSVM
Uncertain
0.72
D
MutationAssessor
Benign
0.97
L;L
PhyloP100
1.9
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.53
N;.
REVEL
Uncertain
0.38
Sift
Uncertain
0.0050
D;.
Sift4G
Uncertain
0.013
D;D
Polyphen
0.98
D;D
Vest4
0.095
MPC
0.17
ClinPred
0.023
T
GERP RS
3.1
Varity_R
0.13
gMVP
0.61
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34280195; hg19: chr20-47989527; API